English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Immunotherapy shows potential for fertility in women with premature ovarian insufficiency
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Novartis and Antares announce cancer drug partnership worth up to $1.9 billion
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

Study finds obesity rates rising and disparities widening across England since pandemic
+ Pharmaceuticals
Patient Daily | Jun 24, 2026

ADC Therapeutics announces layoffs following Zynlonta trial deaths and stock decline
+ Regulatory
A. M. Andrews | Jun 23, 2026

Consumer advocate on 340B drug pricing program: 'Don't let hospital billing ruin American lives'
+ Pharmaceuticals
Patient Daily | Jun 23, 2026

Pfizer continues lung cancer drug trials after Phase 3 study misses survival endpoint
+ Pharmaceuticals
Patient Daily | Jun 23, 2026

US pharma manufacturing salaries surpass average manufacturing and national wages
+ Pharmaceuticals
Patient Daily | Jun 23, 2026

Cambridge researchers identify three biological subtypes of severe pneumonia

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns